ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maine » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Maine

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MAYLENE PERALTA MD

Endocrinology, Diabetes Metabolism

5,797

$1.14M

462
253 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 49%

$197
Average prescription price

Avg: $204

STEPHAN BABIRAK MD

Endocrinology, Diabetes Metabolism

2,188

$412K

353
230 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 49%

$188
Average prescription price

Avg: $204

KATARZYNA SADURSKA MD

Endocrinology, Diabetes Metabolism

2,105

$434K

215
108 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 49%

$206
Average prescription price

Avg: $204

IRWIN BRODSKY MD

Endocrinology, Diabetes Metabolism

1,956

$596K

316
179 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

64%
prescriptions for brand name drugs

Avg: 49%

$305
Average prescription price

Avg: $204

RAHFA ZERIKLY MD

Endocrinology, Diabetes Metabolism

1,304

$372K

213
109 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 49%

$285
Average prescription price

Avg: $204

DANIEL OPPENHEIM M.D.

Endocrinology, Diabetes Metabolism

1,073

$219K

240
166 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 49%

$204
Average prescription price

Avg: $204

WESLEY FAIRFIELD

Endocrinology, Diabetes Metabolism

1,066

$112K

277
163 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 49%

$105
Average prescription price

Avg: $204

MARK HENDERSON MD

Endocrinology, Diabetes Metabolism

1,024

$174K

259
176 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 49%

$170
Average prescription price

Avg: $204

JESSICA ROCKWELL MD

Endocrinology, Diabetes Metabolism

909

$165K

178
95 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 49%

$182
Average prescription price

Avg: $204

EMILY DEMETRIOU MD

Endocrinology, Diabetes Metabolism

664

$149K

96
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 49%

$225
Average prescription price

Avg: $204

ANA MENDOZA-SALAZAR M.D.

Endocrinology, Diabetes Metabolism

624

$130K

119
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 49%

$208
Average prescription price

Avg: $204

CHRISTINE TWINING MD

Endocrinology, Diabetes Metabolism

549

$141K

102
61 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 49%

$257
Average prescription price

Avg: $204

ROBERT BING-YOU MD

Endocrinology, Diabetes Metabolism

476

$42K

115
77 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 49%

$88
Average prescription price

Avg: $204

LAURA TRASK MD

Endocrinology, Diabetes Metabolism

465

$68.8K

104
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 49%

$148
Average prescription price

Avg: $204

DANIEL SPRATT MD

Endocrinology, Diabetes Metabolism

288

$40.8K

65
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

25%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 49%

$142
Average prescription price

Avg: $204

DAVID HOTELLING MD

Endocrinology, Diabetes Metabolism

244

$27.2K

58
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 49%

$112
Average prescription price

Avg: $204

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank